Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Blood (2016) 128 (16): 2096–2097.

https://doi.org/10.1182/blood-2016-07-728766

Published: 2016

Journal Articles

Time-dependent changes in mortality and transformation risk in MDS

Blood (2016) 128 (7): 902–910.

https://doi.org/10.1182/blood-2016-02-700054

Published: 2016

Includes: Supplemental data

Journal Articles

Myelodysplastic Syndromes with I(17)(q10) and Prognostic Implications of Mutations of TP53 and SETBP1

Blood (2014) 124 (21): 1910.

https://doi.org/10.1182/blood.V124.21.1910.1910

Published: 2014

Journal Articles

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

Blood (2014) 124 (21): 3240.

https://doi.org/10.1182/blood.V124.21.3240.3240

Published: 2014

Journal Articles

Time Changes In Predictive Power Of MDS Prognostic Scores – Effects On Revised Scores Such As The IPSS-R, Impact Of Age

Blood (2013) 122 (21): 1544.

https://doi.org/10.1182/blood.V122.21.1544.1544

Published: 2013

Journal Articles

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Blood (2012) 120 (21): 702.

https://doi.org/10.1182/blood.V120.21.702.702

Published: 2012

Journal Articles

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Blood (2012) 120 (12): 2454–2465.

https://doi.org/10.1182/blood-2012-03-420489

Published: 2012

Includes: Supplemental data

Journal Articles

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

David Valcárcel, MD, Vera Adema, Mar Mallo, Margarita Ortega, PhD, Benet Nomdedeu, MD, Guillermo Sanz, MD, Elisa Luño, MD, Del CaÃ‘izo Consuelo, MD, PhD, Javier De la Serna, MD, PhD, Maita Ardanaz, MD, Victor Marco, MD, Rosa Collado, Blanca Xicoy, MD, Francesc Sole, PhD, Teresa Vallespi, MD, PhD

Blood (2011) 118 (21): 1724.

https://doi.org/10.1182/blood.V118.21.1724.1724

Published: 2011

Journal Articles

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Julia Montoro, MD, Teresa Vallespi, MD, PhD, Esther Sancho, MD, Olga Salamero, MD, Laura Lopez-Andreoni, MD, Carmen sanchez-Morata, MD, Mayda Navarrete, MD, Margarita Ortega, PhD, Sabela Bobillo, MD, Noelia Valdez, MD, Francesc Bosch, MD, PhD, David Valcárcel, MD

Blood (2011) 118 (21): 5026.

https://doi.org/10.1182/blood.V118.21.5026.5026

Published: 2011

Journal Articles

T(8;22)(q24;q11) In a Context of Complex Karyotype In Two Patients with B-Cell Lymphoma with Features Intermediate Between Burkitt Lymphoma and Diffuse Large B Cell Lymphoma B (LB/LDCGB)

Teresa Vallespi, MD, PhD, Margarita Ortega, PhD, Anny Jaramillo, MD, Laura Lopez-Andreoni, MD, Noemi Martínez-Morgado, Carmen Sánchez, MD, Francesc Bosch, MD, PhD

Blood (2010) 116 (21): 5093.

https://doi.org/10.1182/blood.V116.21.5093.5093

Published: 2010

Journal Articles

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

Blood (2009) 114 (22): 1750.

https://doi.org/10.1182/blood.V114.22.1750.1750

Published: 2009

Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Blood (2009) 114 (22): 290.

https://doi.org/10.1182/blood.V114.22.290.290

Published: 2009

Journal Articles

Title:Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Untreated Patients with Poor Risk Large B-Cell Lymphoma. A Phase 2 Study Conducted by the Spanish PETHEMA Group.

Noelia Purroy, Andrés López, Teresa Vallespi, MD.PhD., Mercedes Gironella, Juan Bergua, MD, Juan Manuel Sancho, MD

Blood (2009) 114 (22): 2701.

https://doi.org/10.1182/blood.V114.22.2701.2701

Published: 2009

Journal Articles

Global DNA Methylation Status of CD4+ T-Cell Population in Mielodysplastic Syndromes.

Angel Guerra-Moreno, Carlos Palacio, MD, Noemí Martínez-Morgado, Margarita Ortega, Maida Navarrete, M.D., Carmen Sánchez-Morata, M.D., Laura Gallur, MD, Javier Bueno, Teresa Vallespi, MD.PhD.

Blood (2009) 114 (22): 4424.

https://doi.org/10.1182/blood.V114.22.4424.4424

Published: 2009

Journal Articles

Malignant Lymphoma in Primary Sjögren Syndrome: Incidence and Risk Factors.

Andrés López, Roser Solans-Laque, Josep A Bosch-Gil, Mercedes Gironella, Noelia Purroy, Campillo Marta, Teresa Vallespi, MD.PhD..

Blood (2009) 114 (22): 4991.

https://doi.org/10.1182/blood.V114.22.4991.4991

Published: 2009

Journal Articles

Therapy-Related PML-RARα Leukemia: An Emerging Disease. Report of 10 Cases From One Department of Hematology.

Maida Navarrete, MD, Teresa Vallespi, MD, PhD, Anny Jaramillo, MD, Carmen Sánchez-Morata, MD, Carlos Palacio, MD, Noemí Martínez-Morgado, Ángel Guerra-Moreno, Margarita Ortega, PhD, Javier Bueno, MD

Blood (2009) 114 (22): 1016.

https://doi.org/10.1182/blood.V114.22.1016.1016

Published: 2009

Journal Articles

Idiopathic Cytopenia of Undetermined Significance (ICUS): Impact of Flow Cytometry Immunophenotyping (FCI) in the Diagnosis of Myelodysplastic Syndrome (MDS) When Morphology Is Not Conclusive.

Patricia Font, MD, Dolores Subira, PhD, Javier Loscertales, MD, Eva Arranz, PhD, Arancha Alonso, MD, M. Angeles Perez-Saenz, PhD, Antonio Escudero, PhD, Jose Maria Fernandez-Rañada, PhD, Teresa Vallespi, PhD

Blood (2007) 110 (11): 2467.

https://doi.org/10.1182/blood.V110.11.2467.2467

Published: 2007

Journal Articles

Large Field Virtual Microscopy as a Tool for Quality Control and Blast Definitions in MDS and Leukemia. From the International Working Group on MDS.

Jean E. Goasguen, John M. Bennett, Barbara Bain, Richard Brunning, Maria-Teresa Vallespi, Christopher Cox, Ghulam G. Mufti

Blood (2006) 108 (11): 2616.

https://doi.org/10.1182/blood.V108.11.2616.2616

Published: 2006

Journal Articles

Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone

Maria-Luz Sanchez, Julia Almeida, David Gonzalez, Marcos Gonzalez, Maria-Antonia Garcia-Marcos, Ana Balanzategui, Maria-Consuelo Lopez-Berges, Josep Nomdedeu, Teresa Vallespi, Marcos Barbon, Alejandro Martin, Pilar de la Fuente, Guillermo Martin-Nuñez, Javier Fernandez-Calvo, Jesus-Maria Hernandez, Jesus F. San Miguel, Alberto Orfao

Blood (2003) 102 (8): 2994–3002.

https://doi.org/10.1182/blood-2003-01-0045

Published: 2003

Journal Articles

NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)

Roberto Rosati, Roberta La Starza, Angelo Veronese, Ana Aventin, Christine Schwienbacher, Teresa Vallespi, Massimo Negrini, Massimo F. Martelli, Cristina Mecucci

Blood (2002) 99 (10): 3857–3860.

https://doi.org/10.1182/blood.V99.10.3857

Published: 2002

NARROW

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Time-dependent changes in mortality and transformation risk in MDS

Myelodysplastic Syndromes with I(17)(q10) and Prognostic Implications of Mutations of TP53 and SETBP1

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

Time Changes In Predictive Power Of MDS Prognostic Scores – Effects On Revised Scores Such As The IPSS-R, Impact Of Age

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

T(8;22)(q24;q11) In a Context of Complex Karyotype In Two Patients with B-Cell Lymphoma with Features Intermediate Between Burkitt Lymphoma and Diffuse Large B Cell Lymphoma B (LB/LDCGB)

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Title:Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Untreated Patients with Poor Risk Large B-Cell Lymphoma. A Phase 2 Study Conducted by the Spanish PETHEMA Group.

Global DNA Methylation Status of CD4+ T-Cell Population in Mielodysplastic Syndromes.

Malignant Lymphoma in Primary Sjögren Syndrome: Incidence and Risk Factors.

Therapy-Related PML-RARα Leukemia: An Emerging Disease. Report of 10 Cases From One Department of Hematology.

Idiopathic Cytopenia of Undetermined Significance (ICUS): Impact of Flow Cytometry Immunophenotyping (FCI) in the Diagnosis of Myelodysplastic Syndrome (MDS) When Morphology Is Not Conclusive.

Large Field Virtual Microscopy as a Tool for Quality Control and Blast Definitions in MDS and Leukemia. From the International Working Group on MDS.

Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone

NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only